HEALTH UTILITY IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (RR-DLBCL) PATIENTS - RESULTS OF A PHASE II TRIAL WITH ORAL SELINEXOR

Casasnovas, RO; Daniele, P; Tremblay, G; Maerevoet, M; Zijlstra, J; Follows, G; Vermaat, JSP; Kalakonda, N; Goy, AH; Choquet, S; Van den Neste, E; Hill, BT; Thieblemont, C; Cavallo, F; de la Cruz, F; Kuruvilla, J; Hamad, N; Bouabdallah, R; Jager, U; Caimi, P; Gurion, R; Warzocha, K; Bakhshi, S; Sancho, JM; Schuster, M; Egyed, M; Offner, F; Vasilakopoulos, T; Samal, P; Nagy, A; Ku, M; Albendea, MAC

VALUE IN HEALTH, 2020; 23 (): S479